IN2013MU03221A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03221A
IN2013MU03221A IN3221MU2013A IN2013MU03221A IN 2013MU03221 A IN2013MU03221 A IN 2013MU03221A IN 3221MU2013 A IN3221MU2013 A IN 3221MU2013A IN 2013MU03221 A IN2013MU03221 A IN 2013MU03221A
Authority
IN
India
Prior art keywords
film
moisture
curving
sticky
melt
Prior art date
Application number
Inventor
Siraj Daud Anwar
Prakash Sapkal Nidhi
Nandkumar Bonde Minal
Original Assignee
Zim Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zim Lab Ltd filed Critical Zim Lab Ltd
Priority to UAA201605185A priority Critical patent/UA123893C2/en
Priority to MYPI2016701359A priority patent/MY184297A/en
Priority to CA2927334A priority patent/CA2927334C/en
Priority to PCT/IN2014/000652 priority patent/WO2015083181A2/en
Priority to EA201690751A priority patent/EA038558B1/en
Priority to IN3221MU2013 priority patent/IN2013MU03221A/en
Priority to BR112016008356-3A priority patent/BR112016008356B1/en
Publication of IN2013MU03221A publication Critical patent/IN2013MU03221A/en
Priority to CL2016000880A priority patent/CL2016000880A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Abstract

This invention comprises an Oral Thin Film that is instantly wettable, rapid dissolving, non-sticky, non-tacky and non-curving, the said Film capable of carrying an active ingredient for oral delivery being a moisture stabilized film that remains non-sticky and non-curving when exposed to 70±5 % RH (Relative Humidity) at 25°C for at least 2 minutes up to 2 hours in open conditions without packaging.; and a process/method of making them. The active ingredient may comprise, without limitation, an active pharmaceutical, nutraceutical or cosmaceutical ingredient The processes/method comprising (a) drying a casted film in two or more stages, (b) drying of the film after casting is done alternately both the sides, (c) coating the dried film with synthetic water insoluble moisture resistant/moisture repellant hydrophobic polymers that does not melt at high temperature, (d) adding a synthetic water insoluble moisture resistant/moisture repellant hydrophobic polymer that does not melt at high temperature to the solution to be casted as a film.
IN3221MU2013 2013-10-14 2014-10-13 IN2013MU03221A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
UAA201605185A UA123893C2 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
MYPI2016701359A MY184297A (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
CA2927334A CA2927334C (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
PCT/IN2014/000652 WO2015083181A2 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
EA201690751A EA038558B1 (en) 2013-10-14 2014-10-13 Water soluble pharmaceutical film with enhanced stability
IN3221MU2013 IN2013MU03221A (en) 2013-10-14 2014-10-13
BR112016008356-3A BR112016008356B1 (en) 2013-10-14 2014-10-13 PROCESS/METHOD FOR PREPARING A WATER-SOLUBLE FILM OF RAPID ORAL DISSOLUTION AND THIN ORAL FILM
CL2016000880A CL2016000880A1 (en) 2013-10-14 2016-04-14 Water soluble pharmaceutical coating with improved stability

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3221MU2013 IN2013MU03221A (en) 2013-10-14 2014-10-13

Publications (1)

Publication Number Publication Date
IN2013MU03221A true IN2013MU03221A (en) 2015-07-03

Family

ID=53274239

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3221MU2013 IN2013MU03221A (en) 2013-10-14 2014-10-13

Country Status (8)

Country Link
BR (1) BR112016008356B1 (en)
CA (1) CA2927334C (en)
CL (1) CL2016000880A1 (en)
EA (1) EA038558B1 (en)
IN (1) IN2013MU03221A (en)
MY (1) MY184297A (en)
UA (1) UA123893C2 (en)
WO (1) WO2015083181A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3082767A4 (en) * 2013-12-17 2017-05-24 Zim Laboratories Limited Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
BR112019018388A2 (en) * 2017-03-30 2020-04-07 Intelgenx Corp treatment method and device to increase the biological availability of leukotriene receptor antagonists
FR3082851B1 (en) * 2018-06-25 2022-09-02 Biomerieux Sa METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5947987B2 (en) * 1979-10-08 1984-11-22 富士写真フイルム株式会社 Matsuto film that can be added/edited
US4664859A (en) * 1983-12-02 1987-05-12 Vcf Films Inc. Div. Of Pmc Process for solvent casting a film
US5272191A (en) * 1991-08-21 1993-12-21 Fmc Corporation Cold water soluble films and film forming compositions
US6966960B2 (en) * 2003-05-07 2005-11-22 Hewlett-Packard Development Company, L.P. Fusible water-soluble films for fabricating three-dimensional objects
WO2005084636A2 (en) * 2004-02-27 2005-09-15 Ranbaxy Laboratories Limited A process for the preparation of controlled-release pharmaceutical composition of metoprolol
WO2006080630A1 (en) * 2004-09-23 2006-08-03 Handok Pharmaceuticals Co., Ltd. Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus
US20090162516A1 (en) * 2007-12-21 2009-06-25 Brown Solomon E Edible, water-soluble film

Also Published As

Publication number Publication date
WO2015083181A2 (en) 2015-06-11
EA038558B1 (en) 2021-09-14
MY184297A (en) 2021-03-31
EA201690751A1 (en) 2016-08-31
CL2016000880A1 (en) 2017-01-27
UA123893C2 (en) 2021-06-23
WO2015083181A3 (en) 2015-12-03
CA2927334C (en) 2023-08-29
CA2927334A1 (en) 2015-06-11
BR112016008356B1 (en) 2022-12-13
BR112016008356A2 (en) 2017-08-01

Similar Documents

Publication Publication Date Title
CY1120492T1 (en) A DRUG RELEASE FORMAT
BR112018073703A2 (en) skin or wound patch, pharmaceutical composition and method for the release of an active substance
BR112016002205A2 (en) orodispersible films
MX2017008939A (en) Dosage form incorporating an amorphous dgug solid solution.
SG10201808743VA (en) Compositions comprising electrohydrodynamically obtained fibres for administration of specific dosages of an active substance to skin or mucosa
AR063468A1 (en) PHARMACEUTICAL COMPOSITIONS
WO2010042798A3 (en) Modified silk films containing glycerol
MX356111B (en) Immediate release, abuse deterrent pharmaceutical compositions.
IL299897B2 (en) Multi-unit drug delivery devices and methods
IN2013MU03221A (en)
MY167777A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
WO2015107544A3 (en) Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them
DK3793534T3 (en) ORAL TABLET FOR DELIVERY OF ACTIVE INGREDIENTS TO THE GASTROINTESTINAL TRACT
WO2013013038A3 (en) Doping agents and polymeric compositions thereof for controlled drug delivery
PH12015502556A1 (en) Modified release formulation
EA201390979A1 (en) COMPOSITIONS OF BENZIMIDAZOLES WITH MODIFIED SURVIVAL
BR112014032583A2 (en) pharmaceutical form for prolonged release of active substances
WO2016140933A3 (en) Immediate release soluble ibuprofen compositions
BR112017002719A2 (en) lactide block copolymer and preparation method
PH12016500693A1 (en) Slow-release solid oral compositions
BR112015010243A2 (en) solid dispersion, oral administration composition, pharmaceutical composition, and method for preparing a solid dispersion
JP2014521778A5 (en)
HRP20191746T1 (en) Stabilized desmopressin
WO2018108939A3 (en) Solid oral pharmaceutical dosage form with extended active principle release comprising mirabegron
GB2509460A (en) Coating Composition